ALSAC St. Jude Children's Research Hospital
Meets Standards

Standards For Charity Accountability
Governance
-
Board Oversight
-
Board Size
-
Board Meetings
-
Board Compensation
-
Conflict of Interest
Measuring Effectiveness
-
Effectiveness Policy
-
Effectiveness Report
Finances
-
Program Expenses
-
Fundraising Expenses
-
Accumulating Funds
-
Audit Report
-
Detailed Expense Breakdown
-
Accurate Expense Reporting
-
Budget Plan
Fundraising & Info
-
Truthful Materials
-
Annual Report
-
Website Disclosures
-
Donor Privacy
-
Cause Marketing Disclosures
-
Complaints
ALSAC St. Jude Children's Research Hospital meets the 20 Standards for Charity Accountability.
Stated Purpose:
"to advance cures, and means of prevention, for pediatric catastrophic diseases through research and treatment."
Year, State Incorporated:
1957, IL
Also Known As:
St. Jude Children's Research Hospital American Lebanese Syrian Associated Charities ALSAC
ALSAC/St. Jude Children's Research Hospital (ALSAC/St. Jude) states it treats and defeats childhood cancer and other life-threatening diseases. The organization reports being the only National Cancer Institute devoted to children that has been designed as a Comprehensive Cancer Center. Treatments invented at ALSAC/St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent. ALSAC/St. Jude is working to drive the overall survival rate for childhood cancer to 90 percent. The organization reports that it freely shares the discoveries it makes and that families never receive a bill from ALSAC/St. Jude for treatment, travel, housing or food. Some ($110,300,000 or 7%) of ALSAC/St. Jude's program activities are carried out in conjunction with fundraising appeals.
For the year ended June 30, 2023, ALSAC St. Jude Children's Research Hospital's program expenses were:
Patient care services | $662,358,000 |
Research | $675,380,000 |
Education, training, and community services | $311,651,000 |
Total Program Expenses | $1,649,389,000 |
Chief Executive
Richard C. Shadyac, President and Chief Executive Officer (ALSAC) James Downing, MD (St. Jude);, President and CEO
Compensation*
$1,851,107
Chair of the Board
Frederick M. Azar, Chair, ALSAC; Judy Habib, Chair, St. Jude MD,
Chair's Profession / Business Affiliation
Frederick M. Azar, MD (ALSAC), Chief of Staff and Orthopedic Surgeon, Campbell Clinic; Judy Habib (St. Jude), CEO and President, KHJ Brand Activation
Board Size
37
Paid Staff Size
7811
*2022 compensation includes annual salary and, if applicable, benefit plans, expense accounts, and other allowances.
Note 1: The salary listed above was paid to James R. Downing as President/Chief Executive Officer of St. Jude Children's Research Hospital. Richard C. Shadyac, Jr., Chief Executive Officer of ALSAC, was paid $1,361,911for the same period.
Note 2: Joseph P. Taylor , Execuitve Vice President/Scientific Director, St. Jude, was the highest paid employee, receiving 2,320,694 in compensation.
Method(s) Used:
Direct mail appeals, Grant proposals, Internet, Direct mail appeals, Radio, Special events, Telemarketing, Foundation grants, Print advertisements, Corporate solicitation
ALSAC St. Jude Children's Research Hospital incurred joint costs of $199,300,000 for informational materials and activities that included fund raising materials. Of those costs $110,300,000 was allocated to program expenses, $71,200,000 was allocated to fundraising expenses, and $17,800,000 was allocated to administrative expenses.
Fundraising costs were 16% of related contributions. (Related contributions, which totaled $2,457,562,000, are donations received as a result of fundraising activities.)
This organization is tax-exempt under section 501(c)(3) of the Internal Revenue Code. It is eligible to receive contributions deductible as charitable donations for federal income tax purposes.
The following information is based on ALSAC St. Jude Children's Research Hospital's audited financial statements for the year ended June 30, 2023.
Source of Funds
In-kind contributions | $12,308,000 |
Special events, net | $22,938,000 |
Other | $60,010,000 |
Research grants and contracts | $147,585,000 |
Patient service revenue, net | $153,766,000 |
Investment income, net | $479,296,000 |
Bequests | $666,132,000 |
Contributions, cash and financial assets | $1,756,184,000 |
Total Income | $3,298,219,000 |
Programs: 70% Fundraising: 17% Administrative: 13%
Total Income | $3,298,219,000 |
Total expenses: | $2,371,432,000 |
Program expenses | $1,649,389,000 |
Fundraising expenses | $403,601,000 |
Administrative expenses | $318,442,000 |
Other expenses | $0 |
Income in Excess of Expenses | $926,787,000 |
Beginning Net Assets | $9,275,669,000 |
Other Changes In Net Assets | $-534,000 |
Ending Net Assets | $10,201,922,000 |
Total Liabilities | $419,883,000 |
Total Assets | $10,621,805,000 |
Note 1: In the financial section above, "other changes in net assets" refers to a loss from disposal of property and equipment.
Note 2: For the year ended June 30, 2023, ALSAC/St. Jude reported in-kind donations of $12,308,000 including building materials and supplies ($5,537,000), services ($4,027,000), household items ($1,302,000), intangible assets ($950,000), vehicles ($476,000), and equipment ($16,000).
An organization may change its practices at any time without notice. A copy of this report has been shared with the organization prior to publication. It is not intended to recommend or deprecate, and is furnished solely to assist you in exercising your own judgment. If the report is about a charity and states the charity meets or does not meet the Standards for Charity Accountability, it reflects the results of an evaluation of information and materials provided voluntarily by the charity. The name Better Business Bureau is a registered service mark of the International Association of Better Business Bureaus.
This report is not to be used for fundraising or promotional purposes.